ÂÜÀòÂÒÂ×

David Soto is a skilled scientist specializing in drug discovery and cancer biology, currently working at Orna Therapeutics since October 2020 and holding positions from Associate Scientist to Scientist. Prior experience includes a role as Senior Research Associate at SQZ Biotechnologies, where contributions focused on novel cell therapies and murine tumor kinetics studies. David also served as Research Assistant II at Brigham and Women's Hospital, leading projects on the HPV16 E7 oncoprotein in cervical cancer, and as a Research Assistant at The Schepens Eye Research Institute, investigating gene roles in retinal development. David earned a Bachelor of Science in Biochemistry from Boston College in 2015.